Stockscreener 앱 받기
41.13
2.51%
-1.06
전일 마감가:
$42.19
열려 있는:
$41.84
하루 거래량:
800.40K
Relative Volume:
1.11
시가총액:
$2.24B
수익:
$1.28B
순이익/손실:
$-222.15M
주가수익비율:
-10.06
EPS:
-4.09
순현금흐름:
$145.52M
1주 성능:
-5.82%
1개월 성능:
-10.10%
6개월 성능:
-17.66%
1년 성능:
-14.88%
1일 변동 폭
$41.02
$41.93
1주일 범위
$41.02
$44.76
52주 변동 폭
$32.48
$57.35
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
LIVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
41.13 | 2.30B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
What markets is LivaNova PLC expanding into Is EDBL stock a good long term investment optionExpert Picks Review With Low Risk - jammulinksnews.com
Should I hold or sell LivaNova PLC stock in 2025Daily Trading Tips That Work - jammulinksnews.com
How does LivaNova PLC generate profit in a changing economyValue Investing Outlook With Proven Results - jammulinksnews.com
What institutional investors are buying LivaNova PLC stockBeginner Investor Review Backed By Experts - jammulinksnews.com
Is it the right time to buy LivaNova PLC stockChart Pattern Strategy To Watch Now - jammulinksnews.com
Why LivaNova PLC is moving todayPortfolio Diversification Stock Ideas From Experts - metal.it
Jefferies Reaffirms ‘Buy’ Rating on LivaNova PLC (LIVN) with $79 PT - MSN
Trend Reversal Possible in LivaNova PLC Charts IndicatePrice Action Based Buy Opportunity List Published - metal.it
Vagus Nerve Stimulators Market [2025-2032]Exclusive Report - openPR.com
What makes LivaNova PLC stock price move sharplyWeekly Watchlist of High Movers Released - metal.it
10 Most Undervalued Foreign Stocks to Buy According to Analysts - Insider Monkey
Europe Defibrillator Market Forecast and Company Analysis - GlobeNewswire
Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott - Yahoo Finance
Sector Leaders Rotate Capital Into LivaNova PLCBreakout Momentum Picks With Protection Outlined - metal.it
Why LivaNova PLC stock attracts strong analyst attentionChart-Based Trade Entries Gain Analyst Support - beatles.ru
LivaNova PLC Company Revenue and Profit Trends: A Deep DiveMulti-Bagger Potential Stock Forecast Tools Released - metal.it
How does LivaNova PLC compare to its industry peersOutperformance with explosive growth - jammulinksnews.com
Why is LivaNova PLC stock attracting strong analyst attentionCapitalize on strong market momentum - jammulinksnews.com
What is LivaNova PLC company’s growth strategyRobust investment performance - jammulinksnews.com
Does LivaNova PLC stock perform well during market downturnsBreakneck growth rates - jammulinksnews.com
When is LivaNova PLC stock expected to show significant growthMaximize your portfolio’s earning potential - jammulinksnews.com
What is the risk reward ratio of investing in LivaNova PLC stockMaximize your gains with professional insights - jammulinksnews.com
Published on: 2025-07-28 01:55:48 - jammulinksnews.com
LivaNova’s VNS Therapy Shows Sustained Effectiveness in Drug-Resistant Epilepsy - Insider Monkey
Will LivaNova PLC stock benefit from interest rate changesFree Risk Assessment Services - jammulinksnews.com
How CPBI stock compares to its top competitorsIs LivaNova PLC stock undervalued or overvalued nowMarket-beating performance - jammulinksnews.com
Is LivaNova PLC a good long term investmentUnprecedented market success - PrintWeekIndia
What analysts say about LivaNova PLC stockMarket-leading capital gains - Autocar Professional
External Pacemakers Market Set to Witness Significant Growth - openPR.com
What drives LivaNova PLC stock priceBreakthrough financial growth - Autocar Professional
LivaNova PLC Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional
Cardiac Autonomic Control Market Growth in Future Scope - openPR.com
Neurological Implants Market is projected to reach US$ 12.39 - openPR.com
In-Line Blood Monitoring Devices Market is projected to grow - openPR.com
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Livanova Plc 주식 (LIVN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bianchi Francesco | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
10,938 |
| SCHERMERHORN TODD C | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
9,473 |
| KOZY WILLIAM A | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
4,840 |
0 |
33,148 |
| Barry James Christopher | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
4,772 |
| Story Brooke | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
6,892 |
| Enxing Seng Stacy | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
12,161 |
| WILVER PETER M | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
7,148 |
| Tezel Ahmet | Chief Innovation Officer |
Jun 15 '25 |
Option Exercise |
0.00 |
2,967 |
0 |
2,967 |
| Bolton Stephanie | President, Global Epilepsy |
Mar 30 '25 |
Option Exercise |
0.00 |
6,024 |
0 |
15,586 |
| Makatsaria Vladimir | Chief Executive Officer |
Mar 30 '25 |
Option Exercise |
0.00 |
9,330 |
0 |
9,330 |
1.21%
0.17%
자본화:
|
볼륨(24시간):